Back
No. FOA title Description  Funding Amount Funding Period Funder Letter of intent due date Link
1 Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (“de-implement”) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation of research methods and measures are encouraged. Applications that focus on the re-implementation of evidence-based health services (e.g. cancer screening) that may have dropped off amidst the ongoing COVID pandemic are encouraged.  Application budgets are not limited 5 years National Institute of Health (NIH) 30 days prior to the application due date https://grants.nih.gov/grants/guide/pa-files/PAR-22-105.html
2 Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed) The purpose of this Funding Opportunity Announcement is to promote development of innovative, enabling tools and technologies in the areas of kidney, urologic, and hematologic diseases.   $275,000  2 years. National Institute of Health (NIH) Not Applicable https://grants.nih.gov/grants/guide/pa-files/PAR-20-140.html
3 Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for projects to expand, improve, or transform the utility of mammalian cancer and tumor models for translational research. With this FOA, the NCI intends to encourage submission of projects devoted to demonstrating that mammalian models or their derivatives used for translational research are robust representations of human biology, are appropriate to test questions of clinical importance, and provide reliable information for patients’ benefit.  $450,000 per year 5 years. National Institute of Health (NIH) Not Applicable https://grants.nih.gov/grants/guide/pa-files/PAR-20-131.html
4 Innovations in HIV Prevention, Testing, Adherence and Retention to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional) This Funding Opportunity Announcement (FOA) seeks innovative research to optimize HIV prevention and care which is aligned with NIMH Division of AIDS Research (DAR) priorities. Applications may include formative basic behavioral and social science to better understand a step or steps in the HIV prevention or care continuum, and/or the initial development and pilot testing of innovative intervention approaches. Applicants are encouraged to read current Notices of Special Interests (NOSIs) from NIMH DAR for further information about the Division’s research priorities.  Application budgets are not limited 5 years. National Institute of Health (NIH) Not Applicable https://grants.nih.gov/grants/guide/pa-files/PA-20-144.html
5 Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34 Clinical Trial Optional) This Funding Opportunity Announcement (FOA) encourages formative research, intervention development, and pilot-testing of interventions. Primary scientific areas of focus include the feasibility, tolerability, acceptability and safety of novel or adapted interventions that target HIV prevention or treatment. For the purposes of this FOA, “intervention” is defined to include behavioral, social, or structural approaches, as well as combination biomedical and behavioral, social, or structural approaches that prevent acquisition and transmission of HIV infection, or improve clinical outcomes for persons who are HIV infected, or both.  USD 450,000 3 years. National Institute of Health (NIH) Not Applicable https://grants.nih.gov/grants/guide/pa-files/PA-20-141.html
6 Occupational Safety and Health Research (R01) The goal of this Funding Opportunity Announcement (FOA) is to provide funding support for the pre-clinical and early stage clinical (Phase I) development of novel small-molecule and biologic therapeutic agents that prevent Alzheimer’s disease (AD), slow its progression or treat its cognitive and behavioral symptoms.  USD 1,600,000  4 years National Institute of Health (NIH) Not Applicable https://grants.nih.gov/grants/guide/pa-files/PAR-18-812.html
7 NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required) This funding opportunity announcement (FOA) supports investigator initiated low risk clinical trials addressing the mission and research interests of NIDCD. Clinical trials must meet ALL the following criteria: meet the budget limits of this FOA, not require FDA oversight, are not intended to formally establish efficacy and have low risks to potentially cause physical or psychological harm.  up to $500,000 per year 5 years. National Institute of Health (NIH) Not Applicable https://grants.nih.gov/grants/guide/pa-files/PAR-21-063.html
8 Priority HIV/AIDS Research within the Mission of the NIDDK (R01 Clinical Trial Optional) This Funding Opportunity Announcement (FOA) seeks to stimulate HIV/AIDS research within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) that align with the HIV/AIDS research priorities outlined by the NIH Office of AIDS Research (OAR).  Application budgets are not limited 5 years. National Institute of Health (NIH) Not Applicable https://grants.nih.gov/grants/guide/pa-files/PAS-21-031.html
9 Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) The purpose of this funding opportunity announcement (FOA) is to encourage applications that will perform basic, translational and clinical research to (1) advance the understanding of underlying mechanisms of drug action; (2) discover and develop novel therapeutics; (3) enhance the usage of existing drugs or drug repurposing for safer and more effective treatment for pregnant women, lactating women, neonates and children. The overall goal is to improve drug safety and efficacy for maternal and pediatric precision therapeutics. $275,000 2 years National Institute of Health (NIH) 30 days prior to application receipt date https://grants.nih.gov/grants/guide/pa-files/PAR-20-299.html
10 Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional) The purpose of this funding opportunity announcement (FOA) is to encourage applications that will perform basic, translational and clinical research to (1) advance the understanding of underlying mechanisms of drug action; (2) discover and develop novel therapeutics; (3) enhance the usage of existing drugs or drug repurposing for safer and more effective treatment for pregnant women, lactating women, neonates and children. The overall goal is to improve drug safety and efficacy for maternal and pediatric precision therapeutics.  Application budgets are not limited 5 years National Institute of Health (NIH) 30 days prior to application receipt date https://grants.nih.gov/grants/guide/pa-files/PAR-20-300.html
11 Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) encourages grant applications to support research in established cancer epidemiology cohort studies, defined as studies that have achieved their initial planned recruitment goal. Applications must include hypothesis-based research using data from an established cohort study and are expected to include support for cohort maintenance, continued follow-up, and sharing of the existing resources in addition to addressing research questions across the cancer control continuum.  Application budgets are not limited 5 years. National Institute of Health (NIH) Not applicable https://grants.nih.gov/grants/guide/pa-files/PAR-22-162.html
12 Implementation Research to Reduce Noncommunicable Disease (NCD) Burden in Low- and Middle-Income Countries (LMICs) and Tribal Nations During Critical Life Stages and Key Transition Periods (R01 Clinical Trial Optional) This Funding Opportunity Announcement (FOA) supports innovative approaches to identifying, understanding, developing, and implementing strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, tools, policies, and guidelines. In addition, studies to advance dissemination and implementation research methods and measures into application are encouraged. Specifically, this FOA invites applications that propose interventions targeting critical life stages (e.g., infancy, childhood, adolescence, pregnancy, older adults) and key transitions between life stages to reduce health risk and/or enhance positive health and lifestyle behaviors.  Application budgets are not limited 5 years National Institute of Health (NIH) 30 days before receipt date https://grants.nih.gov/grants/guide/pa-files/PAR-22-132.html
13 Partnerships for the Development of Novel Therapeutics to Combat Select Antibiotic Resistant Bacteria and Fungi (R01 Clinical Trial Not Allowed) The purpose of this Funding Opportunity Announcement (FOA) is to solicit research applications for milestone-driven projects focused on preclinical development of lead candidate therapeutics and related countermeasures against antibiotic resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacteriaceae, or Candida auris. Applications must include a Product Development Strategy attachment. Substantive investment by industrial participants is highly encouraged.  $650,000 per year 5 years. National Institute of Health (NIH) 30 days prior to the application due date https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-22-028.html
14 Laboratories to Optimize Digital Health (R01 Clinical Trial Required) NIMH seeks applications for innovative research projects to test strategies to increase the reach, efficiency, effectiveness, and quality of digital mental health interventions which may impact mental health outcomes, including suicide behaviors and serious mental illness. This Funding Opportunity Announcement (FOA) is intended to support the development of digital health test beds that leverage well-established digital mental health platforms and infrastructure to rapidly refine and optimize existing evidence-based digital health interventions and to conduct clinical research testing digital mental health interventions that are statistically powered to provide a definitive answer regarding the intervention’s effectiveness particularly in populations who experience health disparities and vulnerable populations.  Application budgets are not limited 4 years. National Institute of Health (NIH) 30 days prior to the application due date https://grants.nih.gov/grants/guide/pa-files/PAR-22-154.html
15 Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allowed) The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications on the optimization and characterization of technologies and assays with the potential for utilization and adoption in regulatory submissions of genome editing therapeutics. $300,000 per year  3 years National Institute of Health (NIH) June 17, 2022 https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-22-014.html?utm_medium=email&utm_source=govdelivery
16 NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed) This NIDCR Small Grant Program for New Investigators supports basic and clinical research conducted by scientists who are in the early stages of establishing an independent research career in oral, dental and craniofacial research. This R03 program supports pilot or feasibility studies and developmental research projects with the intention of obtaining sufficient preliminary data for a subsequent investigator­ initiated Research Project Grant (R01) or equivalent application. $200,000 two years National Institute of Health (NIH) Not applicable https://grants.nih.gov/grants/guide/pa-files/PAR-21-084.html
17 New Technologies for the In vivo Delivery of Gene Therapeutics for an HIV Cure (R01 Clinical Trial Not Allowed) The purpose of this Funding Opportunity Announcement (FOA) is to support research on the development and validation of innovative strategies to deliver anti-HIV gene therapies efficiently to specific target cells in vivo.  Application budgets are not limited 5 years. National Institute of Health (NIH) 30 days prior to the application due date https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-20-076.html
18 Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) This funding opportunity announcement (FOA) encourages applications for research in cancer control and population sciences. The overarching goal is to provide support to promote research efforts on novel scientific ideas that have the potential to substantially advance cancer research in statistical and analytic methods, epidemiology, cancer survivorship, cancer-related behaviors and behavioral interventions, health care delivery, and implementation science.  USD 250,000 per year 5 years National Institute of Health (NIH) Not Applicable https://grants.nih.gov/grants/guide/pa-files/PAR-18-869.html
19 Enhancing Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and Support Recovery (R21 – Clinical Trial Not Allowed) The National Institutes of Health (NIH) is inviting applications for an Exploratory/Developmental Research Grant. This Funding Opportunity Announcement (FOA) encourages exploratory and developmental research to better understand the role of social connectedness and/or loneliness in prevention, treatment, and recovery from substance use disorders (SUDs). Research may use a variety of approaches, including leveraging existing data sources, survey research, social network analysis, new methods development, feasibility research, etc. Outcomes of interest include any of the following: substance use initiation, escalation, SUD diagnosis, connection to treatment, and engagement or retention in treatment or recovery.  USD 275,000 2 years National Institute of Health (NIH) Not applicable. https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-009.html
20 Enhancing Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and Support Recovery (R34 – Clinical Trial Optional) The National Institutes of Health (NIH) is inviting applications for this planning grant. This Funding Opportunity Announcement (FOA) encourages pilot work and preliminary research to support preparation for large-scale, rigorous trials examining strategies to address social connectedness and/or loneliness in order to prevent or treat SUDs or enhance recovery. The goal of this FOA is to develop user-centered interventions addressing social connectedness and loneliness in the context of substance use that is effective, practical, cost-effective, scalable, and sustainable.  USD 450,000 3 years National Institute of Health (NIH) Not applicable. https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-010.html
21 Lipids in Brain Aging and Alzheimers Disease (AD) and its Related Dementias (ADRD) (R01 Clinical Trial Not Allowed) The goal of this Funding Opportunity Announcement (FOA) is to support research addressing critical knowledge gaps in our understanding of how lipids contribute to vulnerability and resilience to brain aging and Alzheimer’s disease (AD) and its related dementias (ADRD) $500,000  5 years National Institute of Health (NIH) May 15, 2022 https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-009.html
22 Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional) The purpose of this FOA is to encourage research that addresses the link between social disconnection in late-life and late-life suicidal thoughts and behaviors. Of specific interest is research that identifies mechanisms by which social disconnection confers risk for, and social integration protects against, suicidal thoughts and behaviors in late life. Application budgets are not limited 5 years National Institute of Health (NIH) 30 days prior to the application due date https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-135.html
23 HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed) The purpose of this Funding Opportunity Announcement (FOA) is to support multi-component, multi-disciplinary projects that address scientific questions relevant to AIDS prophylactic vaccine discovery research. Extensive evaluation of vaccine concepts in non-human primate models may be included.  USD 2,500,000  5 years National Institute of Health (NIH) Not Applicable https://grants.nih.gov/grants/guide/pa-files/PAR-21-024.html
24 Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R21- Clinical Trial Not Allowed) The purpose of this FOA is to encourage research investigating the roles of extracellular RNA (exRNA) carrier subclasses in biological processes relevant to substance use disorders (SUDs) and/or HIV infection, latency, or pathogenesis in the CNS. Applicants may propose to investigate biological mechanisms involving exRNA carrier subclasses, or propose to develop improved technologies to investigate extracellular vesicles or other exRNA carriers.  USD 275,000 2 years National Institute of Health (NIH) Not Applicable https://grants.nih.gov/grants/guide/pa-files/par-20-147.html
25 Advancing communication strategies to support future HIV vaccine use (R21 Clinical Trial Optional) The National Institutes of Health (NIH) is inviting applications for this Research Project Grant. This Funding Opportunity Announcement (FOA) invites applications for Research Project Grants (R21) that will advance novel health communication research designed to inform and support the acceptance and uptake of future vaccines that protect against HIV.   USD 275,000 2 years National Institute of Health (NIH) 30 days prior to application due date https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-171.html
26 Partnerships for Rapid Diagnostics and Phenotypic Antibacterial Susceptibility Testing for Bacteremia or Hospital Acquired Pneumonia (R01 Clinical Trial Not Allowed) The purpose of this Funding Opportunity Announcement (FOA) is to support research projects focused on development and/or production of medical diagnostics that permit rapid differential species identification, and corresponding phenotypic antibacterial susceptibility profiles for bacteremia or hospital acquired pneumonia. The primary goal of such diagnostics is to facilitate antibacterial stewardship, thereby reducing selective pressure and improving patient outcomes.  up to $500,000 per year 5 years National Institutes of Health (NIH)

National Institute of Allergy and Infectious Diseases (NIAID)

30 days prior to the application due date https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-22-010.html
27 Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional This Funding Opportunity Announcement (FOA) will support the development and characterization of state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative, multidisciplinary projects that engage the fields of regenerative medicine, tissue engineering, biomaterials, and bioengineering with cancer biology will be essential for generating novel experimental models that mimic cancer pathophysiology in the context of a testable cancer research hypothesis $400,000 per year 5 years National Institutes of Health (NIH) 30 days prior to the application due date https://grants.nih.gov/grants/guide/pa-files/PAR-22-099.html
28 Planning Grant for Global Infectious Disease Research Training Program (D71 –  Clinical Trials Not Allowed) The application should propose a collaborative process to create a new training program that will strengthen the capacity of the LMIC institution to conduct infectious disease research  $100,000 (total direct costs) per year 2 years National Institute of Health (NIH) September 28, 2021 https://grants.nih.gov/grants/guide/pa-files/PAR-19-362.html#
29 Innovations in HIV Prevention, Testing, Adherence and Retention to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional) This Funding Opportunity Announcement (FOA) seeks innovative research to optimize HIV prevention and care which is aligned with NIMH Division of AIDS Research (DAR) priorities. Applications may include formative basic behavioral and social science to better understand a step or steps in the HIV prevention or care continuum, and/or the initial development and pilot testing of innovative intervention approaches. Applicants are encouraged to read current Notices of Special Interests (NOSIs) from NIMH DAR for further information about the Division’s research priorities.  up to $275,000 2 years National Institute of Health (NIH) Not applicable https://grants.nih.gov/grants/guide/pa-files/PA-20-145.html
30 Research Project Grant (Parent R01 Clinical Trial Required) The NIH Research Project Grant supports a discrete, specified, circumscribed project in areas representing the specific interests and competencies of the investigator(s). This Parent Funding Opportunity Announcement requires that at least 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions.  Budgets are not limited 5 years National Institute of Health (NIH) Not applicable https://grants.nih.gov/grants/guide/pa-files/pa-20-183.html
31 NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) The NIH Research Project Grant supports a discrete, specified, circumscribed project in areas representing the specific interests and competencies of the investigator(s). The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions.  Budgets are not limited 5 years National Institute of Health (NIH) Not applicable https://grants.nih.gov/grants/guide/pa-files/PA-20-185.html
32 Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) he purpose of this Funding Opportunity Announcement (FOA) is to stimulate translation of scientific discoveries and engineering developments in imaging, data science and/or spectroscopic technologies into methods or tools that address contemporary problems in understanding the fundamental biology, potential risk of development, diagnosis, treatment, and/or disease status for cancer or other disease.  Not limited Not specified National Institute of Health (NIH) Not applicable https://www.fundsbeeline.com/Funding/view_opportunity/13496/OPP017310.html
33 NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required) The NIH Exploratory/Developmental Grant supports exploratory and developmental research projects by providing support for the early and conceptual stages of these projects  USD 275,000 2 years National Institute of Health (NIH) Not applicable https://www.fundsbeeline.com/Funding/view_opportunity/2318/OPP003263.html
34 Tobacco Regulatory Science (R01 Clinical Trial Optional) The purpose of this Funding Opportunity Announcement (FOA) is to invite R01 applications to support biomedical and behavioral research that will provide scientific data to inform regulation of tobacco products to protect public health.  $500,000 Not specified National Institute of Health (NIH) 60 days prior to the application due date https://www.fundsbeeline.com/Funding/view_opportunity/13489/OPP017303.html
35 Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required) The purpose of this FOA is to support the early stage testing of pharmacologic interventions with novel mechanisms of action or device-based interventions for the treatment of symptoms or domains of altered functions in individuals with mental illness (e.g., schizophrenia, depression, autism, obsessive compulsive disorder, anxiety, bipolar disorder).  not limited 5 years National Institute of Health (NIH) 30 days prior to the application due date https://grants.nih.gov/grants/guide/pa-files/PAR-21-137.html
36 Lipids in Brain Aging and Alzheimer’s Disease (AD) and its Related Dementias (ADRD) (R01 Clinical Trial Not Allowed) The goal of this Funding Opportunity Announcement (FOA) is to support research addressing critical knowledge gaps in our understanding of how lipids contribute to vulnerability and resilience to brain aging and Alzheimer’s disease (AD) and its related dementias (ADRD), including research addressing how: 1) lipid droplets affect brain aging and AD, including whether their accumulation is pathological or protective; (2) the periphery interacts with lipids in the aging brain, including whether these could be targets for future biomarkers; (3) APOE and lipid-mediated signaling influence brain aging and AD/ADRD progression; and (4) myelin lipids and their signaling contribute to brain aging and AD/ADRD.  $500,000 5 years National Institute of Health (NIH) May 15, 2022 https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-009.html
37 HEAL Initiative: Planning Studies for Initial Analgesic Development Initial Translational Efforts [Small Molecules and Biologics] (R34 Clinical Trial Not Allowed) The goal of this funding opportunity announcement (FOA) is to solicit Initial Analgesic Development R34 applications that propose 2-year exploratory/planning awards that are expected to enable a future application for RFA-NS-21-015  $500, 000 per year 2 years National Institute of Health (NIH) 30 days prior to the application due date https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-016.html?utm_medium=email&utm_source=govdelivery
38 Clinical Studies of Mental Illness (Collaborative R01 Clinical Trial Optional) This Funding Opportunity Announcement (FOA) seeks to support collaborative clinical studies, not involving treatment development, efficacy, or effectiveness trials.  not limited  5 years National Institute of Health (NIH) Not applicable https://grants.nih.gov/grants/guide/pa-files/PAR-19-297.html
39 Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) This funding opportunity announcement (FOA) provides funding to conduct pharmacodynamic, pharmacokinetic, and in vivo efficacy studies to demonstrate that proposed therapeutic agent(s) have sufficient biological activity to warrant further development to treat neurological or neuromuscular disorders that fall under the NINDS mission.  USD 499,000 per year 3 years National Institute of Health (NIH) Not applicable https://grants.nih.gov/grants/guide/pa-files/PAR-21-122.html
40 Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)  FIC will support research-training programs that focus on major endemic or life-threatening emerging infectious diseases, neglected tropical diseases, infections that frequently occur as co-infections in HIV infected individuals or infections associated with non-communicable disease conditions of public health importance in LMICs.   $230,000 per year 5 years. National Institute of Health (NIH) 30 days prior to the application due date https://grants.nih.gov/grants/guide/pa-files/PAR-20-229.html
41 Applied global health research Medical Research Council (MRC) invites applications for Applied global health research. The applied global health research board supports applied research that will be of direct and primary benefit to the health of vulnerable populations. They are looking for research projects that will develop practical solutions to health challenges. The research question might involve different disciplines and approaches from outside the health sector, but the primary objective must be health-focused.  British Pounds 1,000,000 Not specified Medical Research Council (MRC) Not Applicable https://www.ukri.org/opportunity/applied-global-health-research/
42 Research and Innovation for Global Health Transformation – Call 5 The NIHR fifth Research and Innovation for Global Health Transformation (RIGHT) call will support targeted research to strengthen health service delivery and resilience in low and middle-income countries (LMICs) in the context of extreme weather events. The NIHR is seeking programmes of applied health research that can strengthen health service delivery and resilience in LMICs in the context of extreme weather events caused by the changing climate.  £3 million) 5 years National Institute for Health Research(NIHR) Not Applicable https://www.nihr.ac.uk/funding/research-and-innovation-for-global-health-transformation-call-5/30022?utm_source=partner&utm_medium=email&utm_campaign=right5
43 Susan S. Spencer, MD, Clinical Research Training Scholarship in Epilepsy This two-year award supports clinical research training in the field of epilepsy. It is hoped that this program, targeting clinicians who are fellows or new faculty, will foster the development of clinical care providers interested in pursuing careers in patient-oriented research. The late Susan Spencer, MD, an internationally renowned epileptologist, exemplified the qualities of a clinician-investigator. The award recognizes the importance of good clinical research and encourages young investigators in clinical studies in epilepsy.. $65,000 per year 2 years American Academy of Neurology (AAN) Not Applicable https://www.fundsbeeline.com/funding/view_opportunity/OPP019026
44 Clinical Research Training Scholarship in ALS Funded by The ALS Association and American Brain Foundation in collaboration with the American Academy of Neurology. This award aims to recognize the importance of good clinical research and to encourage young investigators in clinical studies.  $65,000 per year 2 years American Academy of Neurology (AAN) Not Applicable https://www.fundsbeeline.com/funding/view_opportunity/OPP019012
45 Clinical Research Training Scholarship in FTD Funded by Holloway Family Fund of The Association for Frontotemporal Degeneration and American Brain Foundation in collaboration with the American Academy of Neurology. This award aims to recognize the importance of good clinical research and to encourage young investigators in clinical studies.  $65,000 per year 2 years American Academy of Neurology (AAN) Not Applicable https://www.fundsbeeline.com/funding/view_opportunity/OPP019013
46 INVEST Drug Abuse Research Fellowship The National Institute on Drug Abuse (NIDA) International Program INVEST Drug Abuse Research Fellowship combines postdoctoral research training in the United States with professional development activities and grant-writing guidance to form a unique program for drug abuse scientists. Fellows may conduct their research in any aspect of the biomedical or behavioral science of drug abuse and addiction. Previous fellows have conducted research in all aspects of drug abuse and addiction, from social science to basic science, including epidemiology, prevention, treatment, and preclinical and clinical sciences. Fellows and their mentors are encouraged to develop jointly and seek funding for a collaborative research project to be conducted in the fellow’s home country. Fellows and their U.S. mentors are part of a network of international scientists who exchange information and collaborate on drug abuse research nationally, regionally, and globally.  Not Specified 2 years National Institute on Drug Abuse (NIDA) Not Applicable https://www.fundsbeeline.com/funding/view_opportunity/OPP014330
47 Addressing Diagnostic Challenges for Non-Alcoholic Steatohepatitis (NASH) PFIZER intends to provide an independent grant(s) to an organization or organizations that will focus on developing educational programs to help inform about the diagnosis of Non-Alcoholic Steatohepatitis (NASH) beyond biopsy by applying non-invasive tools for NASH and the use of real-world data to develop predictive models that identify the patients at risk of progressing into advanced stages of liver disease.  USD 500,000 2 years Pfizer Inc Not Applicable https://cdn.pfizer.com/pfizercom/2022-05/GMG_2022-IM-G_AddressingDiagnosticChallengesNASH.pdf?6DPaOQCd6N8FbXDyz.bgD8dGgyA6AA8O
48 William T. Grant Scholars Program The William T. Grant Scholars Program supports career development for promising early-career researchers. The program funds five-year research and mentoring plans that significantly expand researchers’ expertise in new disciplines, methods, and content areas. Applicants should have a track record of conducting high-quality research and an interest in pursuing a significant shift in their trajectories as researchers. They recognise that early-career researchers are rarely given incentives or support to take measured risks in their work, so this award includes a mentoring component, as well as a supportive academic community. Awards are based on applicants’ potential to become influential researchers and their plans to expand their expertise in new and significant ways. The application should make a cohesive argument for how the applicant will boost his or her expertise. The research plan should evolve in conjunction with the development of new expertise, and the mentoring plan should describe how the proposed mentors will support applicants in acquiring that expertise. Proposed research plans must address questions that are relevant to policy and practice in the Foundation’s focus areas.  USD 350,000 5 years William T. Grant Foundation Not Applicable http://wtgrantfoundation.org/grants/william-t-grant-scholars-program#awards
49 Global Convening Programmes The Global Convening programme aims to provide significant opportunities for researchers in the UK and internationally across the humanities and social sciences globally to network, open new fields of inquiry, and harness research to address these challenges aiming to catalyse change in industry, practice, policy and society, and support collaborative exploration across disciplines and borders. £500,000 per annum Not specified British Academy Not Applicable https://www.fundsbeeline.com/funding/view_opportunity/OPP023089
50 Small conservation grants The Jana Robeyst trust fund (JRTF) wishes to support scientists financially on a small scale, with amounts up to a maximum of 1500 euro per application. It is often difficult for researchers to find funding for small projects. They would also fund travel to a seminar and the purchase of equipment.  EURO 1,500 Not Applicable Jana Robeyst Trust Fund Not Applicable http://janatrustfund.org/index_en.html
51 Access to Quality Early Childhood Care and Education in Emergencies (ECCE) Activity The United States Government (USG), represented by the U.S. Agency for International Development (USAID) Mission in Ethiopia (USAID|Ethiopia), in partnership with The LEGO Foundation, is seeking applications from qualified entities to implement the Early Childhood Care & Education in Emergencies Activity through a five-year Cooperative Agreement mechanism (USAID) and a Partnership Agreement (The LEGO Foundation).  $46 million 5 years United States Agency for International Development (USAID) Not Applicable https://www.grants.gov/web/grants/view-opportunity.html?oppId=339568
52 Richard Olney Clinician Scientist Development Award in ALS Funded by The ALS Association and American Brain Foundation in collaboration with the American Academy of Neurology. The award recognizes the importance of good clinical research and encourages young investigators in clinical studies in ALS.  $75,000 per year 3 years American Academy of Neurology (AAN) Not Applicable https://www.fundsbeeline.com/funding/view_opportunity/OPP019043
53 McKnight Clinical Translational Research Scholarship in Cognitive Aging and Age-Related Memory Loss Funded by the McKnight Brain Research Foundation through the American Brain Foundation, and the American Academy of Neurology. This award aims to support young investigators in clinical studies relevant to age-related cognitive decline and memory loss. The award also recognizes the importance of rigorous training in clinical research and encourages young investigators in seeking opportunities to establish future careers in the area of human cognitive aging. Please note: the focus should NOT be solely on a neurodegenerative dementia (e.g. Alzheimer’s disease); however, proposals that focus on combined study of cognitive aging and neurodegenerative cognitive changes may be considered. $65,000 per year 2 years American Academy of Neurology (AAN) Not Applicable https://www.fundsbeeline.com/funding/view_opportunity/OPP019025
54 AFREhealth Competitive Funding Award call 2022-1 The AFREhealth Secretariat invites competitive applications from African universities to undertake innovative priority research, training, and education programs which include the development of evidence-based guidance documents in health professions education and research relevant to the African context. Applications that involve more than two AFREhealth universities will be prioritized. The funding awards are for a project period not exceeding twelve months at the end of which there should be demonstrable products including at least one submitted manuscript to a peer-reviewed journal that acknowledges the funding support. Satisfactory accountability of funds endorsed by one’s parent institution is an absolute requirement after completion of the project. For this round, up to 20 competitive applications may be awarded.  up to 20,000USD 12 months African Forum for Research and Education in Health 11th April 2022 https://afrehealth.org/award/notice-of-funding-award
55 Call for Innovation Research Grants on Responsible Artificial Intelligence for Climate Action The Call for Proposals is aimed at competitively identifying eight (8) innovation research projects in Responsible AI for Climate Action in Africa. The general objective of the Network is to advance climate action in Africa through the responsible development and deployment of artificial intelligence innovations.  USD 60,000 18 months RUFORUM Not Applicable https://ruforum.wordpress.com/2022/04/28/call-for-innovation-research-grants-onresponsible-artificial-intelligence-for-climate-action/
56 Upcoming: Applied global health research The applied global health research board supports applied research that will be of direct and primary benefit to the health of vulnerable populations. We’re looking for research projects that will develop practical solutions to health challenges. This includes:

late-stage intervention development
global health trials
implementation and scale-up research
health systems research
health economics
health policy research
research with a predominantly applied focus that does not fit within the remit of other MRC boards and panels.

 £1 million Not specified Medical Research Council (MRC) Not applicable https://www.ukri.org/opportunity/applied-global-health-research/
57 Wellcome Early-Career Awards This scheme provides funding for early-career researchers from any discipline who are ready to develop their research identity. Through innovative projects, they will deliver shifts in understanding that could improve human life, health and wellbeing. By the end of the award, they will be ready to lead their own independent research programme.  £400,000 5 years Wellcome Trust Not applicable https://wellcome.org/grant-funding/schemes/early-career-awards
58 Wellcome Career Development Awards This scheme provides funding for mid-career researchers from any discipline who have the potential to be international research leaders. They will develop their research capabilities, drive innovative programmes of work and deliver significant shifts in understanding that could improve human life, health and wellbeing. Application budgets are not limited 8 years Wellcome Trust Not applicable https://wellcome.org/grant-funding/schemes/career-development-awards
59 Wellcome Discovery Awards This scheme provides funding for established researchers and teams from any discipline who want to pursue bold and creative research ideas to deliver significant shifts in understanding that could improve human life, health and wellbeing. Application budgets are not limited 8 years Wellcome Trust Not applicable https://wellcome.org/grant-funding/schemes/discovery-awards
60 E.W. “Al” Thrasher
Awards
The purpose of the E.W. “Al” Thrasher Awards is
to improve children’s health through medical
research, with an emphasis on projects that have
the potential to translate into clinically
meaningful results within a few years. The Fund
awards grants two times per year, with no fixed
number of awards given in each funding cycle or
in each year.
$370,000 3 years Thrasher
Research Fund
July 19, 2022 https://www.thrasherresearch.org/al-thrasher-award?lang=eng
61 Tackling diseases (Single Stage – 2022) (HORIZON-HLTH-2022-DISEASE-07)            Non-communicable diseases risk reduction in adolescence and youth (Global Alliance for Chronic Diseases – GACD) This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 3 “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim for delivering results that are directed, tailored towards and contributing to some of the following expected outcomes:
Health care practitioners and providers in low- and middle-income countries (LMICs) and those in high-income countries (HICs) serving vulnerable populations have access to and use specific guidelines to implement prevention interventions able to support adolescents and young people to decrease future risks of developing NCDs.
 €25 000 000 Not specified European Commission Not Applicable https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-hlth-2022-disease-07-03
62 Pandemic preparedness – HORIZON-HLTH-2022-DISEASE-07-02 This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 3 “Tackling diseases and reducing disease burden under this topic should aim for delivering results that are directed, tailored towards and contributing to some of the following expected outcomes:
The scientific community has better understanding of the biology of the pathogens (virus, bacteria etc.), its transmission, its interaction with humans, animals and plants, in particular in view of emerging threats to human health, such as infectious diseases and anti-microbial resistance.
€ 10,000,000 Not specified European Commission Not Applicable https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-hlth-2022-disease-07-02
63 Pre-announcement: Public Health Intervention Development (PHIND): Sep 2022 MRC is looking to support the early-stage development of interventions that seek to address either UK or global public health challenges.

This might include qualitative and quantitative primary research and the development of theory and logic models. However, emphasis should be placed on developing the intervention.

This opportunity supports the incorporation of systems thinking when addressing public health challenges. It is justifiable to focus on just one aspect of a system, as long as the wider systems context is recognised. For example, in the framework for evaluation.

It also encourages the use of multi-disciplinary teams and co-production with users and other relevant stakeholders, such as policy makers.

 £150,000 Not specified Medical Research Council (MRC) Not Applicable https://www.ukri.org/opportunity/public-health-intervention-development/?utm_medium=email&utm_source=govdelivery
64 Wellcome Mental Health Data Prize The Wellcome Data Prize in mental health will support collaborative approaches to research into anxiety and depression in young people. Teams in the UK and South Africa will explore existing data to find new insights and build digital tools that enable future research. Data prizes are an open competition or challenge where participants use data to solve a societal problem.  A key aim of this prize is to build a multidisciplinary mental health data community by bringing together people with mental health research backgrounds and data expertise.  By mental health science, they mean any discipline that uses evidence in rigorous and transparent ways, whether based on observation or experimentation. This could include: psychiatry, psychology, neuroscience, and disciplines within the humanities, social sciences, and computer sciences, among others  British Pounds 500,000 Not applicable Wellcome trust Not applicable. https://wellcome.org/grant-funding/schemes/wellcome-mental-health-data-prize#how-to-apply-988d
65 Covid-19: understanding the biological significance of SARS-CoV-2 variants This call is for research into the biological significance of SARS-CoV-2 variants, focused on laboratory investigations in immunology, virology, or structural biology. The goal is to produce research that is relevant and beneficial to low- and middle-income countries. The research must support national policymakers in preventing and controlling the Covid-19 pandemic and should strengthen capability in low- and middle-income countries for a research response to future infectious disease outbreaks. Applicants should consider how to involve and respond to the needs and concerns of relevant public stakeholders and facilitate an open and transparent environment to ensure the research is trustworthy, acceptable to, and supported by relevant communities.  British Pounds 3,000,000 3 years Wellcome trust Not applicable. https://wellcome.org/grant-funding/schemes/covid-19-understanding-biological-significance-sars-cov-2-variants#key-dates-1431
66 Early Career Awards The Fund recognizes that young investigators may find it difficult to remain in pediatric research because of a lack of funding. Thus, the purpose of this program is to encourage the development of medical research in child health by awarding small grants to new researchers, helping them gain a foothold in this vital area. The goal is to fund applicants who will go on to be independent investigators. The Fund is open to a wide variety of research topics and does not focus on a particular disease, but all our funded projects deal directly with children’s health. In the Early Career Award Program, the Fund is particularly interested in applicants that show significant potential to impact that field of children’s health through medical research.  USD 25,000 1-2 years Thrasher Research Fund Not Applicable https://www.thrasherresearch.org/early-career-award?lang=eng
67 Scaling up of cells and stacks for large electrolysers This topic concerns the research and development of much larger cells and stacks for water electrolyzers than the current State of the Art (SoA). By upscaling electrolyzer cells and stacks, economies of scale can be realized in manufacturing and more compact installations can be achieved when integrating electrolyzers into industrial chemical processes, thermal processes, and hydrogen hubs. The application of electrolyzers to industrial clusters and hydrogen hubs in order to achieve substantial CO2 savings is inhibited by the present capacities of electrolyzer stacks. Hydrogen production could be achieved more cost-effectively if larger electrolyzer cells and stacks were available. When compared with the current SoA, the development of an electrolyzer module of about 10MW, if feasible, would be a considerable step forward (where a module comprises the least number of stacks and preferably only one stack).  EURO 121,000,000 Not specified European Commission Not Applicable https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-jti-cleanh2-2022-01-05;callCode=HORIZON-JTI-CLEANH2-2022-2;freeTextSearchKeyword=;matchWholeText=true;typeCodes=1;statusCodes=31094501,31094502,31094
68 Jorma Ollila Grant The Jorma Ollila special fund was created to support recently graduated doctors to further develop their research careers. These personal grants are awarded for the purpose of gaining international experience and research excellence for a period of 1-3 years. In addition to financial support, the new special fund will support the selected applicants through the contact network of the Nokia Foundation.  20 000 € 1-3 years Nokia Foundation Not Applicable http://nokiafoundation.com/grants/jorma-ollila-grant/
69 ISEG Postgraduate Training Fellowship in Medical Statistics for African Scientists The International Statistics and Epidemiology Group( ISEG )Postgraduate Training Fellowship in Medical Statistics for African Scientists launched in 2005 and forms a key part of ISEG’s investment in capacity strengthening. Two fellowships are available, funded by the UK Medical Research Council (MRC) and the Faculty of Epidemiology and Population Health at LSHTM, to provide support for two years of training in medical statistics. For the first year, the successful applicants will study for the MSc degree in Medical Statistics at the London School of Hygiene & Tropical Medicine (LSHTM). This will be followed by a one-year professional attachment at one of the African centres associated with the research programme of the MRC International Statistics and Epidemiology Group (ISEG) at LSHTM. During the professional attachment, training Fellows will develop their statistical and research skills by working on studies with guidance from ISEG scientists. This is intended to foster excellence in the field of medical statistics and epidemiology in sub-Saharan Africa. Not Specified Not specified London School of Hygiene & Tropical Medicine Not Applicable https://www.lshtm.ac.uk/research/centres-projects-groups/mrc-international-statistics-and-epidemiology-group#fellowships
70 Google PhD Fellowship Program – Africa Google PhD Fellowships directly support graduate students as they pursue their PhD, as well as connect them to a Google Research Mentor. Nurturing and maintaining strong relations with the academic community is a top priority at Google. The Google PhD Fellowship Program was created to recognize outstanding graduate students doing exceptional and innovative research in areas relevant to computer science and related fields. Fellowships support promising PhD candidates of all backgrounds who seek to influence the future of technology. Google’s mission is to foster inclusive research communities and encourage people of diverse backgrounds to apply. They currently offer Fellowships in Africa, Australia, Canada, East Asia, Europe, India, New Zealand, Southeast Asia and the United States.  Not Specified Not specified Google Not Applicable https://research.google/outreach/phd-fellowship/
71 HORIZON-HLTH-2022-DISEASE-07  Support for the functioning of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 3 “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim for delivering results that are directed, tailored towards and contributing to some of the following expected outcomes:
International research funders are supported by a dynamic and efficient secretariat in their coordination efforts for a rapid research response when a pandemic or a severe epidemic strikes.
International research funders can rely on a tested framework underpinning a rapid and effective research response, and as such ensure stronger research preparedness and response for public health emergencies, including in cross-cutting areas such as data sharing, social science, clinical trial networks and others.
Research funders, policy makers and the research community are well informed of the activities of GloPID-R members, both as a group and individually.
€ 2,000,000 Not specified European Commission Not Applicable https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-hlth-2022-disease-07-01
72 Women RISE: Research to support women s health and economic empowerment for a COVID-19 Recovery that is Inclusive, Sustainable and Equitable This call for proposals will be available to fund research teams conducting action-oriented, gender-transformative research projects to understand the relationships between women’s work and health before, during, and after COVID-19. Specifically, this funding opportunity will support population and public health research in LMICs that addresses UN Research Roadmap Priority 3.5: “How have recent economic changes disproportionately impacted women and how can recovery strategies be inclusive and gender-transformative?”? CAD 1,000,000 24 months International Development Research Center(IDRC) April 2022 https://idrc.ca/en/upcoming-funding-opportunity-women-rise-research-support-womens-health-and-economic-empowerment?utm_source=Funding+Alerts&utm_campaign=059ff0c775-EMAIL_CAMPAIGN_7_31_2020_9_57_COPY_01&utm_medium=email&utm_term=0_02f2dae0ce-059ff0c775-95
73 Pre-announcement: Turing AI World-Leading Researcher Fellowships: rounds two and three Research should show significant novelty in the development of AI technologies and should go beyond applying established AI approaches within applications. Not specified Not specified UK Research and Innovation Not applicable https://www.ukri.org/opportunity/turing-ai-world-leading-researcher-fellowships-rounds-two-and-three/?utm_medium=email&utm_source=govdelivery
74 Apply for MSc programs MSc programs for 2022-2023 academic year  Not Specified Depends on the programme Skolkovo Institute of Science and Technology (Skoltech) Not applicable https://www.skoltech.ru/en/apply/msc-programs/
75 Global Masters Scholarship The University of Birmingham invites applications for Global Masters Scholarship. Birmingham has a proud heritage of removing barriers to education to enable the most academically talented students to fulfil their potential in learning and education.  In keeping with this tradition, they are proud to be launching the Global Masters Scholarship to attract and support the most academically talented international students from across the world to their Master’s degrees during the 2022/23 academic year. British Pounds 10,000 Depends on the programme University of Birmingham Not applicable https://www.birmingham.ac.uk/postgraduate/funding/global-masters-scholarship.aspx
76 International Capacity Building Fund The purpose of the International Capacity Building (ICB) Fund is to provide resources to enhance education and training of applied microbiology in developing countries.  British Pounds 5,000 Not specified Society for Applied Microbiology Not Applicable https://sfam.org.uk/career/grants/international-capacity-building-fund.html
77 OPTions Initiative – Next-Generation Methods Seed grants are available for innovations that seek to test and develop next-generation methods of pregnancy termination, menses induction, or conception interruption  $250,000 to $400,000 CAD 18 to 24 months Grand Challenges Canada Not applicable https://www.grandchallenges.ca/funding-opportunities/
78 Planning Grant for Global Infectious Disease Research Training Program (D71 No Clinical Trials Allowed) This Funding Opportunity Announcement (FOA) encourages applications for a planning grant from institutions in low- and middle-income countries (LMICs) to 1.) Design a Global Infectious Disease (GID) Research Training Program in collaboration with U.S. collaborators and 2.) Strengthen LMIC faculty and prepare advanced courses and training resources for the program envisioned at the LMIC institution.  $100,000 2 years. National Institutes of Health Not applicable http://grants.nih.gov/grants/guide/pa-files/PAR-19-362.html
79 International Research in Infectious Diseases (R01 Clinical Trial Not Allowed) The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for support of high-priority, regionally relevant infectious disease research by international investigators in resource-constrained countries.  $125,000 per year 5 years National Institute of Allergy and Infectious Diseases (NIAID) 30 days prior to the application due date https://grants.nih.gov/grants/guide/pa-files/PAR-20-108.html
80 Family Planning and Reproductive Health Methods APS The purpose of this APS is to support the research, development, and introduction of technologies and approaches that better meet the needs of women and girls as their sexual and reproductive health concerns change over time $80,000,000 Not specified Agency for International Development Not Applicable https://www.grants.gov/web/grants/view-opportunity.html?oppId=215873
81 Four-year PhD Studentships in Science This scheme offers graduates outstanding training in scientific research.  £88756 4 years Chosen programme Not applicable https://wellcome.org/grant-funding/schemes/four-year-phd-programmes-studentships-basic-scientists
82 Master’s Studentships in Humanities and Social Science This scheme enables researchers to undertake humanities or social science Master’s courses in any area of health.  £16,000 1 year Chosen programme Not applicable https://wellcome.org/grant-funding/schemes/masters-studentships-humanities-and-social-science
83 NIDA Avant-Garde Award Program for HIV/AIDS and Substance Use Disorder Research (DP1, Clinical Trial Optional) This  Award Program for HIV/AIDS Research supports exceptionally creative scientists, who propose high-impact research that will open new areas of HIV/AIDS research in the context of Substance Use Disorders (SUD) and/or lead to new avenues for prevention and treatment of HIV/AIDS in people who use drugs (PWUD).   $700,000 per year 5 years. National Institute on Drug Abuse (NIDA) 30 days prior to the application due date https://grants.nih.gov/grants/guide/pa-files/PAR-20-221.html
84 Basic Education Quality Advancement Addendum No. 72051921R00002 to Higher Education for Leadership, Innovation, and Exchange (HELIX) New Partnerships Initiative (NPI) Annual Program Statement Number (APS) No. 7200AA20APS00009 Through this Basic Education Quality Advancement Addendum, USAID/El Salvador aims to engage locally based new and underutilized partners to expand and amplify the Agency’s work through and with higher education. NPI seeks to support the partner countries’ achievement of sustainable and resilient results, and catalyze more effective partnering for impact.  $25,000,000 five (5) years. El Salvador USAID-San Salvador Not Applicable https://www.grants.gov/web/grants/view-opportunity.html?oppId=333216
85 Fostering balanced brain circulation – ERA Fellowships Fellowships should be provided to excellent researchers, undertaking cross-border mobility either to or between the EU Member States or Horizon Europe Associated Countries. Applications are expected to be made jointly by the researcher together with a beneficiary in the academic or non-academic sector located in a Widening Country.  EURO 8,000,000 Not specified European Commission Not applicable https://www.fundsbeeline.com/Funding/view_opportunity/16169/OPP020478.html
86 Direct renewable energy integration into process energy demands of the chemical industry Pursued technology developments are expected to directly target renewable energy integration into process energy demands of the chemical industry beyond electricity (targeting e.g. electrochemical potential of artificial photosynthesis to chemical reduction processes and/or e.g. direct solar thermochemical conversion) and should improve GHG balance and sustainability of the targeted process.   EURO 10,000,000 Not specified European Commission Not applicable https://www.fundsbeeline.com/Funding/view_opportunity/16042/OPP020332.html
87 Demonstration of complete value chains for advanced biofuel and non-biological renewable fuel production Proposals should demonstrate innovative and cost-effective sustainable value chains for advanced biofuels or synthetic renewable fuels of non-biological origin (other than for hydrogen as a final product), over the entire cycle from feedstock to end-use.  EURO 20,000,000 Not specified European Commission Not applicable https://www.fundsbeeline.com/Funding/view_opportunity/16045/OPP020334.html
88 Higher Education for Leadership, Innovation, and Exchange (HELIX), A New Partnership Initiative (NPI) Agency for International Development HELIX aims to improve partner country higher education individual, institutional, and organizational capacity for change by supoorting opportunities for partnerships, scholarships, exchanges, fellowships, internships, apprenticeships, work based learning, research, communities of practice and other relevant forms of capacity development and change management  $1,000,000 -$60,000,000 5 years Agency for International Development (USAID) None https://www.grants.gov/web/grants/view-opportunity.html?searchOppId=326056&tabId=relatedDocumentsTab&origin=vgo-subscribe
89 Options for Pregnancy Termination Innovation Initiative (“OPTions Initiative”) We are excited to announce the initiative has launched its third round of funding! Seed grants of up to $250,000 CAD are available for innovations that seek to test and develop:

New or improved approaches to increasing early access to existing pregnancy termination products and services in low- and middle-income countries, or
Next-generation methods of pregnancy termination, menses induction or conception interruption

 $250,000 CAD Not specified Grand Challenges Canada Not applicable https://www.grandchallenges.ca/funding-opportunities/
90 2D materials-based devices and systems for biomedical applications (RIA) Proposals should build on the multi-functionality allowed by 2DMs and demonstrate the advantages of combining e.g. biocompatibility, chemical stability, (bio-)sensing and actuating, and integration with flexible electronic technologies, in addition to versatile surface chemistry (for interface with biology) to allow continuous health monitoring and built-in pharmacological interventions.  EURO 6,000,000 not specified European Commission Not applicable https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-cl4-2022-digital-emerging-02-19;callCode=HORIZON-CL4-2022-DIGITAL-EMERGING-02;freeTextSearchKeyword=;matchWholeText=true;typeCodes=1;statusCodes=3109
91 MSCA Doctoral Networks 2022 These doctoral programmes will respond to well-identified needs in various R&I areas, expose the researchers to the academic and non-academic sectors, and offer training in research-related, as well as transferable skills and competencies relevant for innovation and long-term employability (e.g. entrepreneurship, commercialization of results, Intellectual Property Rights, communication  EURO 427,276,125 Not specified European Commission Not applicable https://www.fundsbeeline.com/Funding/view_opportunity/16171/OPP020480.html
92 Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Required)  This Funding Opportunity Announcement (FOA) aims to address urgent, time-sensitive mental health research questions related to COVID-19, including broader secondary impacts of the pandemic as well as research on the intersection of mental health, COVID-19, and HIV. Research supported will improve public health in the near term by informing responses to the current pandemic through rapid acceleration of research to address access, reach, delivery, effectiveness, scalability and sustainability of health assessments and interventions to respond to new and worsening mental illness and HIV-related outcomes among those who experience COVID-19 as well as the broader population impacted by the pandemic. All research is anticipated to focus on particularly vulnerable populations based on existing evidence of increased mental health symptoms and illness and preexisting health disparities.  $750,000 direct costs per year 3 years National Institute of Health (NIH) 30 days prior to the application due date(s) https://grants.nih.gov/grants/guide/pa-files/PAR-22-112.html
93 Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Optional) This Funding Opportunity Announcement (FOA) aims to address urgent, time-sensitive mental health research questions related to COVID-19, including broader secondary impacts of the pandemic as well as research on the intersection of mental health, COVID-19, and HIV. Research supported will improve public health in the near term by informing responses to the current pandemic through 1) understanding mechanisms by which mental illness impacts SARS-CoV-2 morbidity and mortality, 2) exploring how COVID-19 contributes to incident mental illness or HIV-outcomes, 3) identifying modifiable targets uniquely or robustly implicated in the pandemic that are relevant to new and worsening mental illness, and 4) conducting mechanistic trials probing biological or behavioral processes of those targets that may be pursued in future mental health therapeutic development. Research is anticipated to be informed by and directed towards vulnerable populations based on evidence of preexisting and worsened health disparities.  $750,000 direct costs per year 3 years National Institute of Health (NIH) 31 days prior to the application due date(s) https://grants.nih.gov/grants/guide/pa-files/PAR-22-113.html
94 NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed) This Funding Opportunity Announcement (FOA) encourages applications from institutions/organizations that propose to conduct vision-related secondary data analyses utilizing existing database resources. Applications may be related to, but must be distinct from, the specific aims of the original data collection. The NEI supports an extensive portfolio of clinical trials and large-scale epidemiologic research projects wherein numerous data collection activities are required to meet each project’s specific aims. The resultant wealth of data generated by these studies often provides unique, cost-effective opportunities to investigate additional research questions or develop new analytical approaches secondary to a project’s originally-intended purpose. Data are not limited to those collected under NEI support, but such data are of the highest programmatic interest. The purpose of this FOA is for secondary data analysis using existing data sets from vision-related clinical trials, epidemiologic, and other clinical research studies. This FOA may be used to develop new statistical methodologies or test hypotheses using existing data, but this FOA must not be used to support the collection of new data  USD 275,000 2 years National Institute of Health (NIH) Not Applicable https://grants.nih.gov/grants/guide/pa-files/PAR-22-141.html
95 International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed) The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH.  The overarching goal of this R25 program is to support “the ethics of” educational activities that foster a better understanding of biomedical, behavioral and clinical research and its implications. (The overarching goal of this R25 program is to support educational activities that foster a better understanding of “the ethics of” biomedical, behavioral and clinical research and its implications.)  USD 230,000 per year 5 years National Institute of Health (NIH) 07/05/2022, May 6, 2023, May 6, 2024 https://grants.nih.gov/grants/guide/pa-files/PAR-22-118.html
96 Translational Research in Maternal and Pediatric Pharmacology and Therapeutics The purpose of this funding opportunity announcement (FOA) is to encourage applications that will perform basic, translational and clinical research to (1) advance the understanding of underlying mechanisms of drug action; (2) discover and develop novel therapeutics; (3) enhance the usage of existing drugs or drug repurposing for safer and more effective treatment for pregnant women, lactating women, neonates and children. The overall goal is to improve drug safety and efficacy for maternal and pediatric precision therapeutics.  $275,000. 2 years National Institute of Health (NIH) 30 days prior to application receipt date https://grants.nih.gov/grants/guide/pa-files/PAR-20-299.html
97 Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) This FOA supports basic, translational, and/or clinical research projects that seek to identify the mechanisms of therapy-induced adverse sequelae, clinically characterize the adverse sequelae, or translate the mechanistic understanding into therapeutic approaches to prevent or minimize the development of long-term sequelae.  Application budgets are not limited 5 years National Institute of Health (NIH) 30 days prior to the application due date https://grants.nih.gov/grants/guide/pa-files/PAR-21-329.html
98 Agroecological approaches for sustainable weed management A successful proposal should support the farm to fork’s strategy objective of a transition to a fair, healthy and resilient European agriculture, notably its objective to promote agroecology, and the target to reduce the overall use and risk of chemical pesticides, by unfolding the potential of agroecology to provide alternative weeding strategies that reduce or eliminate the use of pesticides used as herbicides.  EURO 14,500,000 Not specified European Commission Not applicable https://www.fundsbeeline.com/Funding/view_opportunity/16187/OPP020497.html
99 Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 – Basic Experimental Studies with Humans) This funding opportunity announcement (FOA) invites basic and/or methodological research projects that illuminate and/or measure independent and interdependent health-related effects within dyads across relationships and settings. For the purpose of this FOA, a dyad is a unit of two individuals whose interactions and influences on one another are nested within larger social contexts and networks.  budgets are not limited 5 years National Institute of Health (NIH) Not applicable https://grants.nih.gov/grants/guide/pa-files/PAR-21-280.html?utm_medium=email&utm_source=govdelivery
100 Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 Clinical Trials Not Allowed) This funding opportunity announcement (FOA) invites basic and/or methodological research projects that seek to illuminate or measure independent and interdependent health-related effects within dyads. For the purpose of this FOA, a dyad is a unit of two individuals whose interactions and influences on one another are nested within larger social contexts and networks. Both animal and human subjects research projects are welcome  Budget not limited 5 years National Institute of Health (NIH) Not applicable https://grants.nih.gov/grants/guide/pa-files/PAR-21-281.html?utm_medium=email&utm_source=govdelivery
101 HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional) The goals of this program are to support locally relevant research in critical areas of HIV-associated non-communicable diseases (NCDs) at Low- and Middle-Income Country (LMIC) Institutions, to enhance research capacity, and to build a network of researchers both within and across LMICs to address this critical burden   $275,000 per year 2 years National Institute of Health (NIH) November 8, 2021 https://grants.nih.gov/grants/guide/pa-files/PAR-21-246.html
102 HEAL Initiative: Planning Studies for Initial Analgesic Development [Small Molecules and Biologics] (R61 Clinical Trial Not Allowed) These R61 awards will support the building of a research team to collect initial data and recruit additional collaborators.  may not exceed $500,000 per year 2 years National Institute of Health (NIH) 30 days prior to application due date. https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-029.html?utm_medium=email&utm_source=govdelivery
103 Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional)  The proposed institutional research training program is expected to sustainably strengthen the NCD research capacity of the LMIC institutions, and to train in-country experts to develop and conduct research on NCDs across the lifespan,  $230,000 per year 5 years National Institute of Health (NIH) 30 days before receipt date https://grants.nih.gov/grants/guide/pa-files/PAR-21-230.html?utm_medium=email&utm_source=govdelivery
104 Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) This Funding Opportunity Announcement (FOA) supports preclinical discovery and development of potential therapeutic Biotechnology Products and Biologics  Application budgets are not limited 2-4 years National Institute of Health (NIH) 30 days prior to the application due date https://grants.nih.gov/grants/guide/pa-files/PAR-21-163.html?utm_medium=email&utm_source=govdelivery
105 HEAL Initiative: Team Research for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development (U19 Clinical Trial Not Allowed) The goal of this FOA is to support team-based research projects to develop assays, screening and early optimization work to develop a non-addictive therapeutic to treat pain  $1.5 million per year  5 years National Institute of Health (NIH) 30 days prior to the application due date https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-015.html?utm_medium=email&utm_source=govdelivery
106 BRAIN Initiative: Optimization of Transformative Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed) This FOA seeks applications to optimize existing or emerging technologies through iterative testing with end users  Not Specified 4 years. National Institute of Health (NIH) 60 days prior to the receipt date https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-027.html
107 BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) to understand how electrical and chemical signals code information in neural circuits and give rise to sensations, thoughts, emotions and actions  not specified 3years National Institute of Health (NIH) Not applicable https://grants.nih.gov/grants/guide/rfa-files/RFA-EY-21-001.html
108 Fertility Status as a Marker for Overall Health (R21 Clinical Trial Not Allowed) The purpose of this FOA is to support exploratory/developmental research that explores the premise that fertility status can be a marker for overall health. Chronic conditions such as cancer, diabetes, and obesity can impair fertility; however, less is known about the extent to which fertility status can impact or act as a marker for overall health.  $275,000 2 years National Institute of Health (NIH) 30 days prior to the application due date https://grants.nih.gov/grants/guide/pa-files/PAR-20-282.html#
109 Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed) This Funding Opportunity Announcement (FOA) is to invite applications from research institutions in low- to middle-income countries (LMIC) to provide senior administrators from these institutions with advanced training in the management of NIH grants.  up to  $100,000 per 18 months may not exceed 18 months. National Institute of Health (NIH) 30 days prior to the application due date https://grants.nih.gov/grants/guide/pa-files/PAR-21-037.html
110 New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial Required)  NIDA is interested in research that addresses gaps related to the delivery of comprehensive, integrated health services to include the full continuum of HIV/AIDS services, addiction prevention and treatment services, and primary care services, with a goal of improving the coordination of care, and improving health outcomes related to HIV and SUD in the US  Application budgets are not limited 5 years. National Institute on Drug Abuse (NIDA) Not Applicable https://grants.nih.gov/grants/guide/pa-files/PAR-20-273.html
111 Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed) The goal of this funding opportunity is to stimulate the use of existing human datasets for well-focused secondary analyses to investigate novel scientific ideas or new models, systems, tools, methods, or technologies that have the potential for significant impact on biomedical or biobehavioral research in areas relevant to the NHLBI mission.  $75,000 per year  2 years. National Institute of Health (NIH) Not Applicable https://grants.nih.gov/grants/guide/pa-files/PAR-20-078.html
112  NEI Vision Research Epidemiology Grant (UG1 Clinical Trial Not Allowed) The National Eye Institute (NEI) supports investigator-initiated, complex, multi-center and other high resource risk epidemiologic studies under the cooperative agreement mechanism, UG1 activity code. Specifically, the purpose of this Funding Opportunity Announcement (FOA) is to support new and innovative ocular epidemiology research.  budgets are not limited 5 years National Institute of Health (NIH) Not Applicable https://grants.nih.gov/grants/guide/pa-files/PAR-21-204.html
113 Detection of HIV for Self-Testing (R61/R33 Clinical Trial Not Allowed) The purpose of this Funding Opportunity Announcement (FOA) is to support collaborative, interdisciplinary early-stage research to inform the development of innovative rapid, sensitive, simple, and cost-effective diagnostic technologies that will enable HIV self-testing during the earliest phases of acute infection or during viral rebound.  $500,000 per year 5 years National Institute of Health (NIH) 30 days prior to the application due date https://grants.nih.gov/grants/guide/pa-files/PAR-21-070.html
114 The HIV Vaccine Research and Design (HIVRAD) Program The purpose of this Funding Opportunity Announcement (FOA) is to support multi-component, multi-disciplinary projects that address scientific questions relevant to AIDS prophylactic vaccine discovery research. Extensive evaluation of vaccine concepts in non-human primate models may be included.  $2.5M per year 5 years National Institute of Health (NIH) 30 days prior to the application due date https://grants.nih.gov/grants/guide/pa-files/par-21-024.html
115 Development & Testing of Novel Interventions to improve HIV Prevention, Treatment, and Program Implementation for People Who Use Drugs (R34 Clinical Trial Required) This Funding Opportunity Announcement (FOA) encourages formative research, intervention development, and pilot-testing of interventions for people who use drugs. Primary outcomes of interest include the feasibility, tolerability, acceptability and safety of novel or adapted interventions that target HIV prevention, treatment or services research.  $450,000 3 years National Institute of Health (NIH) Not applicable https://grants.nih.gov/grants/guide/pa-files/PA-21-205.html
116 Pediatric Immune System – Ontogeny and Development (INTEND) (R01 Clinical Trial Not Allowed) The purpose of this Funding Opportunity Announcement (FOA) is to correlate immune system development patterns between two or more age groups – neonates, infants, and children and adolescents and further understand the impact of infectious diseases, microbiome and environmental factors on the ontogeny and development of the pediatric immune system, from birth, transitioning into adolescence and adulthood with the focus of impact during pregnancy and post-natal period.  $400,000 4 years NIH,                   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Not Applicable https://grants.nih.gov/grants/guide/pa-files/PAR-21-248.html
117 HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) The goal of the program is to accelerate the optimization and development of promising small molecule and biologic hits/leads to Phase I clinical trials and readiness for the Early Phase Pain Investigation Clinical Network (EPPIC-Net) https://heal.nih.gov/research/clinical-research/eppic-net or other Phase II clinical studies.  Budget is not limited 5 years National Institute of Health (NIH) 30 days prior to receipt date. https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-010.html
118 Development and Testing of Novel Interventions to improve HIV Prevention, Treatment, and Program Implementation for People Who Use Drugs (R34 Clinical Trial Required) his Funding Opportunity Announcement (FOA) encourages formative research, intervention development, and pilot-testing of interventions. Primary scientific areas of focus include the feasibility, tolerability, acceptability and safety of novel or adapted interventions that target HIV prevention, treatment or services research for people who use drugs. For the purposes of this FOA, “intervention” may include behavioral, social, or structural approaches, as well as combination biomedical and behavioral approaches that prevent the acquisition and transmission of HIV infection, or improve clinical outcomes for persons living with HIV.  $450,000 3 years National Institute of Health (NIH) Not Applicable https://grants.nih.gov/grants/guide/pa-files/PA-21-205.html
119 Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional) This Funding Opportunity Announcement (FOA) solicits applications for research projects that will apply computational approaches to develop parametrically detailed behavioral assays across mental-health relevant domains of function.  up to $275,000 2 years National Institute of Health (NIH) November 01, 2021,November 01, 2022, November 01, 2023 https://grants.nih.gov/grants/guide/pa-files/PAR-21-264.html
120 Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 – Clinical Trial Optional) The purpose of this Funding Opportunity Announcement (FOA) is to encourage exploratory/developmental research applications that propose to study the development, validation, feasibility, and effectiveness of innovative mobile health (mHealth) interventions or tools specifically suited for low- and middle-income countries (LMICs) that utilize new or emerging technology, platforms, systems, or analytics  R21 – $125,000 per year                            R33 – $200,000 per year  R21 – 2 years          R33-3 years National Institute of Health (NIH) October 16, 2021; October 15, 2022 https://grants.nih.gov/grants/guide/pa-files/PAR-21-303.html
121 Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional) The purpose of this Funding Opportunity Announcement (FOA) is to provide support for new investigators from diverse backgrounds, including from groups nationally underrepresented in biomedical research, to conduct small research projects in the scientific mission areas of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and participating Institutes and Centers.   $125,000 per year 3 years. National Institute of Health (NIH) Not Applicable https://grants.nih.gov/grants/guide/pa-files/PAR-21-313.html
122 Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional) The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications to pursue invasive neural recording studies focused on mental health-relevant questions.  $275,000 2 years. National Institute of Health (NIH) Not Applicable https://grants.nih.gov/grants/guide/pa-files/PAR-21-288.html
123 Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed) The purpose of this Funding Opportunity Announcement (FOA) is to encourage innovative research that will inform and support the delivery of high-quality, continuously improving mental health services to benefit the greatest number of individuals with, or at risk for developing, a mental illness.  Application budgets are not limited 5 years National Institute of Health (NIH) 30 days prior to the application due date https://grants.nih.gov/grants/guide/pa-files/PAR-21-316.html
124 BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed) This FOA seeks exceptionally creative approaches to address major challenges associated with recording and modulating CNS activity, at or near cellular resolution, at multiple spatial and/or temporal scales, in any region and throughout the entire depth of the brain. It is expected that the proposed research may be high-risk, but if successful, could profoundly change the course of neuroscience research.  Application budgets are not limited  3 years. National Institute of Health (NIH) 60 days prior to the receipt date. https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-21-026.html
125 Blueprint MedTech Translator (UG3/UH3 – Clinical Trial Optional) The purpose of this Funding Opportunity Announcement (FOA) is to encourage investigators to pursue translational activities and clinical feasibility studies to advance the development of therapeutic, and diagnostic devices for disorders that affect the nervous or neuromuscular systems.  Application budgets are not limited 4 to 5 years National Institute of Health (NIH) 60 days prior to the application due date. https://grants.nih.gov/grants/guide/pa-files/PAR-21-315.html?utm_medium=email&utm_source=govdelivery
126 Basic Research in Cancer Health Disparities (R03 Clinical Trial Not Allowed) This Funding Opportunity Announcement (FOA) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities.  $50,000 2 years National Institute of Health (NIH) Not Applicable https://grants.nih.gov/grants/guide/pa-files/PAR-21-324.html
127 Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) These research project grants (R01) will support innovative studies designed to investigate biological/genetic bases of cancer health disparities, such as (1) mechanistic studies of biological factors associated with cancer health disparities, including those related to basic research in cancer biology or cancer prevention strategies, (2) the development and testing of new methodologies and models, and (3) secondary data analyses.  Application budgets are not limited 5 years National Institute of Health (NIH) Not Applicable https://grants.nih.gov/grants/guide/pa-files/PAR-21-322.html
128 Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) These awards will support pilot and feasibility studies designed to investigate biological/genetic bases of cancer health disparities, such as (1) mechanistic studies of biological factors associated with cancer health disparities, (2) the development and testing of new methodologies and models, and (3) secondary data analyses.  $275,000 2 years National Institute of Health (NIH) Not Applicable https://grants.nih.gov/grants/guide/pa-files/PAR-21-323.html
129 High Priority HIV and Substance Use Research (R01 Clinical Trial Optional) The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD)  Application budgets are not limited  5 years National Institute of Health (NIH) 30 days prior to the application due date https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-040.html
130 Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) The purpose of the Fogarty Emerging Global Leader Award is to provide research support and protected time (three to five years) to an early career research scientist from a low- or middle-income country (LMIC) who holds a junior faculty position at an LMIC academic or research institution, as defined by the World Bank (http://data.worldbank.org/about/country-classifications/country-and-lending-groups, including “low-income,” “lower-middle-income,” and “upper-middle-income” countries).  Refer to other award budget information 5 years. National Institute of Health (NIH) 30 days before the application due date https://grants.nih.gov/grants/guide/pa-files/PAR-21-252.html
131 Emerging Global Leader Award (K43 Independent Clinical Trial Required) This Funding Opportunity Announcement (FOA) invites applications from LMIC scientists from any health-related discipline who propose career development activities and a research project that is relevant to the health priorities of their country under the mentorship of LMIC and U.S. mentors.  Refer to other award budget information 5 years. National Institute of Health (NIH) 30 days before the application due date https://grants.nih.gov/grants/guide/pa-files/PAR-21-251.html
132 Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) This FOA supports a wide range of cancer research including, but not limited to, biochemical and genetic analyses of cancer risk, as well as discovery and validation of early detection biomarkers. The proposed research project must involve use of PLCO biospecimens and may include other resources; additionally, it should also take advantage of the unique characteristics of the PLCO biospecimens.  Application budgets are not limited 5 years. National Institute of Health (NIH) 30 days prior to the application due date. https://grants.nih.gov/grants/guide/pa-files/PAR-21-330.html
133 AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional) This funding opportunity announcement (FOA) seeks to facilitate the entry of both newly independent and early career investigators to the area of drug use and use disorder research and HIV/AIDS.  $100,000 per year 2 years National Institute of Health (NIH) Not Applicable https://grants.nih.gov/grants/guide/pa-files/PAS-21-270.html
134 Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional) This Funding Opportunity Announcement (FOA) encourages grant applications for the conduct of innovative, collaborative research projects with low- and middle-income country (LMIC) institutions/ scientists on brain and other nervous system function and disorders throughout life, relevant to LMICs.  Application budgets are not limited 5 years National Institute of Health (NIH) 30 days prior to the application due date https://grants.nih.gov/grants/guide/pa-files/PAR-21-311.html
135 Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional) This Funding Opportunity Announcement (FOA) encourages exploratory/developmental research grant applications, piloting innovative, collaborative research projects with low- and middle-income country (LMIC) institutions/ scientists on brain and other nervous system-related function and disorders throughout life, relevant to LMICs.  $125,000 per year 2 years. National Institute of Health (NIH) 30 days before receipt date https://grants.nih.gov/grants/guide/pa-files/PAR-21-319.html
136 Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required)  This funding opportunity announcement (FOA) invites research projects that seek to explain the underlying mechanisms, processes, and trajectories of social relationships and how these factors affect outcomes in human health, illness, recovery, and overall wellbeing.  Application budgets are not limited 5 years National Institute of Health (NIH) Not applicable https://grants.nih.gov/grants/guide/pa-files/PAR-21-352.html
137 Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed) This funding opportunity announcement (FOA) invites research projects that seek to model the underlying mechanisms, processes, and trajectories of social relationships and how these factors affect outcomes in health, illness, recovery, and overall wellbeing.  Application budgets are not limited 5 years National Institute of Health (NIH) Not applicable https://grants.nih.gov/grants/guide/pa-files/PAR-21-350.html
138 The role of Epstein Barr virus (EBV) infection in Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or without an underlying HIV infection (U01 Clinical Trial Optional) This funding opportunity announcement (FOA) focuses on the role of EBV infection on Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or without an underlying HIV infection.  Application budgets are not limited 5 years National Institute of Health (NIH) 30 days prior to the application due date https://grants.nih.gov/grants/guide/pa-files/PAR-21-348.html
139 Infrastructure Development Training Programs for Critical HIV Research at Low-and Middle-Income Country Institutions (G11 Clinical Trials Not Allowed) The overall goal of the Fogarty HIV Research Training (HIVRT) Program is to strengthen the scientific capacity of institutions in low- and middle-income countries (LMICs) by enhancing the functional resources required to conduct HIV research on the evolving HIV epidemic in their countries. $94000 per year  3 years. National Institute of Health (NIH) 30 days before application due date. https://grants.nih.gov/grants/guide/pa-files/PAR-22-153.html
140 Planning Grant for Fogarty HIV Research Training Program for Low- and Middle-Income Country Institutions (D71 Clinical Trial Not Allowed) The Fogarty HIV Research Training (HIVRT) Program supports research training that strengthens HIV research capacity of institutions in low-and middle-income countries (LMICs). This FOA offers an opportunity for LMIC institutions to submit a planning grant application to prepare to participate in the Fogarty HIV Research Training Program.  $ 28,000 per year 2 years National Institute of Health (NIH) 30 days prior to the application due date https://grants.nih.gov/grants/guide/pa-files/PAR-22-152.html
141 Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional) The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications for research training programs to strengthen the scientific capacity of institutions in low- and middle-income countries (LMICs) to conduct HIV research relevant to the evolving HIV epidemic in their country.  $280,000 per year 5 years National Institute of Health (NIH) 30 days before receipt date. https://grants.nih.gov/grants/guide/pa-files/PAR-22-151.html
142 Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed) This Funding Opportunity Announcement (FOA) is soliciting Transformative Research Award applications to support individual scientists or groups of scientists proposing groundbreaking, exceptionally innovative, original, and/or unconventional research that has the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies related to Down syndrome. $6,000,000 five years National Institute of Health (NIH) Not Applicable https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-22-009.html?utm_medium=email&utm_source=govdelivery
143 HEAL Initiative: Team Research for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed) This funding opportunity announcement (FOA) is part of a suite of FOAs to support the development of safe, effective, and non-addictive therapeutics to treat pain. The goal of this FOA is to support interdisciplinary team-based research projects to develop assays, conduct screening and early optimization work followed by pharmacokinetic, pharmacodynamic, and in vivo efficacy studies to demonstrate that proposed therapeutic agent(s) have sufficient biological activity to warrant further development.  $1.5 million per year  5 years National Institute of Health (NIH) 30 days prior to the application due date https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-052.html?utm_medium=email&utm_source=govdelivery
144 Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) This Funding Opportunity Announcement (FOA) will support the development and characterization of state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative, multidisciplinary projects that engage the fields of regenerative medicine, tissue engineering, biomaterials, and bioengineering with cancer biology will be essential for generating novel experimental models that mimic cancer pathophysiology in the context of a testable cancer research hypothesis.  USD 400,000 per year 5 years. National Institute of Health (NIH) 30 days prior to the application due date https://grants.nih.gov/grants/guide/pa-files/PAR-22-099.html
145 Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed) The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications proposing the analysis of this public use dataset to increase knowledge of adolescent health and development.  USD 250,000 5 years. National Institute of Health (NIH) 30 days prior to the application due date https://grants.nih.gov/grants/guide/pa-files/PAR-22-137.html
146 Alcohol Treatment and Recovery Research (R01 Clinical Trial Required) This FOA will focus broadly on topics relevant for treatment of and recovery from alcohol use disorder (AUD), including: medications development, precision medicine, behavioral therapies and mechanisms of behavioral change (MOBC), recovery, translational research, and innovative methods and technologies for AUD treatment and recovery.  Application budgets are not limited 5 years National Institute of Health (NIH) 30 days before application due date https://grants.nih.gov/grants/guide/pa-files/PAR-22-158.html
147 Alcohol Health Services Research (R01 Clinical Trial Optional) This FOA will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this focus, there are five major areas of emphasis: (1) increasing access to treatment for AUD, (2) making treatment for AUD more appealing, (3) examining cost structures and insurance systems, (4) conducting studies on dissemination and implementation of existing evidence-based approaches to treating AUD, and (5) reducing health disparities as a means of addressing the treatment gap in AUD for health disparity populations.  Application budgets are not limited 5 years National Institute of Health (NIH) 30 days prior to the application due date https://grants.nih.gov/grants/guide/pa-files/PAR-22-156.html
148 Innovative Research in Cancer Nanotechnology (IRCN) (R01 Clinical Trial Not Allowed) This Funding Opportunity Announcement (FOA) entitled “Innovative Research in Cancer Nanotechnology (IRCN)” encourages applications promoting transformative discoveries in cancer biology and/or oncology through the use of nanotechnology.  USD 450,000 per year 5 years National Institute of Health (NIH) Not Applicable https://grants.nih.gov/grants/guide/pa-files/PAR-20-284.html
149 Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (“de-implement”) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation of research methods and measures are encouraged. Applications that focus on the re-implementation of evidence-based health services (e.g. cancer screening) that may have dropped off amidst the ongoing COVID pandemic are encouraged  USD 50,000 per year 2 years National Institutes of Health (NIH) Not Applicable https://grants.nih.gov/grants/guide/pa-files/PAR-22-160.html
150 Behavioral & Integrative Treatment Development Program (R34 Clinical Trial Optional) The purpose of this Funding Opportunity Announcement (FOA) is to encourage research grant applications on the development and testing of behavioral and integrative treatments for substance use and dependence. This FOA reaffirms the continued commitment of NIDA to major programs of research on behavioral and integrative treatments. The term “behavioral treatments” is used herein a broad sense and includes but is not limited to psychotherapies, cognitive, relapse prevention, remediation, rehabilitative, skills training, counseling, family, and exercise therapies. Screening, brief, computerized, adherence, prevention interventions for HIV risk behaviors, and interventions that target therapist training and fidelity also are included. Integrative refers to combinations with other treatments, including pharmacotherapies or other complementary approaches.  USD 450,000 3 years National Institutes of Health (NIH) 30 days prior to the application due date https://grants.nih.gov/grants/guide/pa-files/PAR-22-183.html
151 Behavioral & Integrative Treatment Development Program (R01 Clinical Trial Optional) The purpose of this funding opportunity announcement (FOA) is to encourage behavioral intervention development research. Specifically, test efficacy, conduct clinical trials, examine mechanisms of behavior change, determine dose-response, treatment optimization, and/or ascertain best sequencing of behavioral, combined, sequential, or integrated behavioral and pharmacological treatments. Research of interest includes but is not limited to Stage II and Stage III efficacy research, including: (1) drug abuse treatment interventions, including interventions for patients with comorbidities; (2) drug abuse treatment and adherence interventions; (3) drug abuse treatment and adherence interventions that utilize technologies to boost effects and increase implementability and sustainability; (4) interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment; (5) interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and (6) interventions to treat substance misuse and chronic pain.  Application budgets are not limited 5 years National Institutes of Health (NIH) 30 days prior to the application due date https://grants.nih.gov/grants/guide/pa-files/PAR-22-182.html
152 Alzheimer’s Drug-Development Program (U01 Clinical Trial Optional) The goal of this Funding Opportunity Announcement (FOA) is to provide funding support for the pre-clinical and early stage clinical (Phase I) development of novel small-molecule and biologic drug candidates that prevent Alzheimer’s disease (AD), slow its progression, or treat its cognitive and behavioral symptoms. Participants in this program will receive funding for therapy development activities such as medicinal chemistry; pharmacokinetics (PK); Absorption, Distribution, Metabolism, Excretion, Toxicology (ADMET); efficacy in animal models; formulation development; chemical synthesis under Good Manufacturing Practices (GMP); Investigational New Drug (IND) enabling studies; and initial Phase I clinical testing.   $1,500,000 in direct costs per year 4 years National Institutes of Health (NIH) 30 days prior to the application due date https://grants.nih.gov/grants/guide/pa-files/PAR-22-047.html
153 Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) This Funding Opportunity Announcement (FOA) will support extramural research to investigate and mitigate challenges facing clinical assay development and subsequent analytical validation due to preanalytical variability in tumor tissue biopsies, blood biospecimens utilized as “liquid biopsies”, or other biospecimens as described in this FOA.  USD 250,000 per year 5 years. National Institute of Health (NIH) 30 days prior to application due date https://grants.nih.gov/grants/guide/pa-files/PAR-22-049.html
154 Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) The National Institutes of Health (NIH) is inviting applications for this Exploratory/Developmental Research Grant. Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) encourages the submission of exploratory/developmental research grant (R21) applications that focus on different aspects of cancer control by modifying behavior, screening, and understanding etiologic factors contributing to the development of cancer, and developing ways to control cancer.  USD 275,000 2 years National Institute of Health (NIH) 30 days prior to application due date https://grants.nih.gov/grants/guide/pa-files/PAR-21-341.html
155 International Bioethics Research Training Program (D43 Clinical Trial Optional) The overall goal of this initiative is to support the mentored training of a sustainable critical mass of bioethics scholars in low and middle-income country (LMIC) research-intensive institutions with the capabilities to conduct original empirical or conceptual ethics research that addresses challenging issues in health research and research policy in these countries as well as provides research ethics leadership to their institutions, governments, and international research organizations.  USD 230,000 per year 5 years. National Institute of Health (NIH) 30 days prior to application due date https://grants.nih.gov/grants/guide/pa-files/PAR-22-116.html
156 BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional) The purpose of this Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative Funding Opportunity Announcement is to encourage applications that will develop and validate novel tools to facilitate the detailed analysis and manipulation of complex circuits in large brains.  Application budgets are not limited 5 years National Institute of Health (NIH) 30 days prior to application due date https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-115.html
157 C.H.I.L.D.R.E.N!® The project mission is to alleviate disease, seek cures, and ultimately improve the quality of life of children affected with Primary Immunodeficiency throughout the world.  $25,000 per year Upto 2 years Jeffrey Modell Foundation (JMF) None http://www.info4pi.org/medical/research-grants/childrenr
158 Development Innovation Ventures (DIV) (DIV) is USAID’s open innovation program that tests and scales creative solutions to any global development challenge. By investing in breakthrough innovations driven by rigorous evidence, USAID impacts millions of lives at a fraction of the usual cost.  $200,000 – $5,000,000 3 years USAID None https://www.usaid.gov/div
159 AfOx Travel Grants  The overarching aim of the scheme is to foster the development of new collaborations and the scheme is not intended to be used as alternative support for already established collaborations.  up to £5000 1 to 8 weeks Africa Oxford initiative None https://www.opportunitiesforafricans.com/africa-oxford-initiative-afox-travel-grants-2021/
160 ICESCO Prize for Fighting Novel Coronavirus (Covid-19)  The Prize has been earmarked by ICESCO to reward anyone who has discovered an efficient cure or vaccine against Coronavirus. To this effect, the Organization invites independent researchers, group of researchers or research institutions to send their nominations  Up to $200,000 Unavailable Islamic World Educational, Scientific and Cultural Organization (ICESCO) Not Applicable  
161 Expression of Interest:
Vaccine Drug Products in alternative
primary packaging and delivery devices
CEPI is requesting information from vaccine developers and their vaccine manufacturers, who are
looking to establish additional primary packaging and fill/finish capacity, and/or are interested in
a novel delivery device that facilitates mass vaccination.
 Not Specified Not Specified The Coalition for Epidemic Preparedness Innovations (CEPI) Not Applicable https://cepi.net/wp-content/uploads/2020/11/EoI-vaccine-in-bags_text-01Mar21.pdf
162 Grant Funding-Fanconi Anemia Research Fund The Fanconi Anemia Research Fund (FARF) seeks to fund interdisciplinary and translational research efforts that will lead to rapid discovery and development of therapies or strategies that treat, control, or cure Fanconi anemia (FA).  USD 250,000 1-2 years Fanconi Anemia Research Fund (FARF) Not Applicable https://www.fanconi.org/explore/apply-for-grant-funding
163 Main Grants Main Grants are given to large, established organizations working at a regional or national scale that can demonstrate the sustained impact of their programmes, in the areas of to sexual and reproductive health services (SRH) and Nutrition.  between £50,000 and £100,000 1-3 years The Waterloo Foundation (TWF) Not Applicable http://www.waterloofoundation.org.uk/WorldDevelopmentAboutTheProgramme.html
164 Brain Tumor Research Grants  Proposals related to basic and translational projects that can advance understanding of the underlying biology of the development and treatment of PLGA tumors will be considered.  Not specified  Not specified  A Kids’ Brain Tumor Cure Foundation Not Applicable https://akidsbraintumorcure.org/medical-research-on-childhood-brain-tumors/apply-for-a-plga-sponsored-grant/
165 Apply for funding The Draper Richards Kaplan Foundation seeks to dramatically improve the lives of people and the world around us through innovative strategies, systems changing approaches, and disrupting technologies.  Our goal is to find social entrepreneurs with dynamic ideas and nurture them at the early stages with maximum leverage and total commitment.  $300,000 3 years Draper Richards Kaplan Not applicable https://www.drkfoundation.org/apply-for-funding/
166 Mental Health Award: looking backwards, moving forward – understanding how interventions for anxiety, depression, and psychosis work This call provides funding for teams of researchers working across any discipline of relevance to mental health science. They will investigate the causal mechanisms underpinning effective interventions for anxiety, depression, and/or psychosis, to inform the development of new and improved early interventions. Up to £5 million  8 years Wellcome Trust Not applicable https://wellcome.org/grant-funding/schemes/mental-health-award-interventions-anxiety-depression-psychosis
167 Heat adaptation: evaluating interventions to help manage the health effects of heat The award will fund teams led by researchers from low- or middle-income countries (LMIC) to test interventions to manage heat-related health risks in real settings – not under laboratory conditions. By the end of the award, successful applicants will have delivered a high-quality study testing and evaluating a new or existing heat adaptation intervention with the potential to change policy and practice in LMICs.  Between £500,000 and £2 million Up to 5 years Wellcome Trust Not applicable https://wellcome.org/grant-funding/schemes/heat-adaptation-evaluating-interventions-help-manage-health-effects-heat
168 Doctoral Dissertation Grants The 2022 DDG competition and funding is intended to support worthy applicants who have advanced to candidacy (i.e., the dissertation phase) in their doctoral programs and whose dissertation research plans address TIRF’s Research Priorities  USD 5,000 Not Applicable International Research Foundation for English Language Education (TIRF) Not Applicable https://www.tirfonline.org/doctoral-dissertation-grants/
169 A life course approach to common NCD risk factor prevention and reduction The GACD seeks to fund collaborative, multidisciplinary and cross-cultural teams. The teams should include appropriate expertise in implementation research. Other eligibility requirements differ for each funding agency, and can be found in the agency-specific information listed on this page. Research should aim to improve health equity in low- and middle-income countries (LMICs) or among disadvantaged populations in high-income countries (HICs)  EUR 25,000,000 not spceified European Commission (EC) Not applicable https://www.gacd.org/news/2021-11-30-gacd-announces-new-funding-call#:~:text=In%20the%20context%20of%20this,long%20and%20potentially%20intergenerational%20health.
170 Reducing global health non-communicable disease risk for young people Apply for global health funding to reduce the risk of non-communicable diseases through implementation research.

You must:

be based at a UK research organisation eligible for UKRI funding
work in partnership with co-investigators based in low or middle income countries (LMICs) where the work will take place.
Your research must:

take a life course approach
focus on people aged 10 to 24 in LMICs.

 £5,000,000 five years Medical Research Council 19-Apr-22 https://www.ukri.org/opportunity/reducing-global-health-non-communicable-disease-risk-for-young-people/
171 The USAID Global Health Broad Agency Announcement for Research and Development (2018) This Broad Agency Announcement (BAA) seeks opportunities to co-create, co-design, co-invest, and collaborate in the research, development, piloting, testing, and scaling of innovative, practical and cost-effective interventions to address the most pressing problems in global health.  not specified Not specified United States Agency for International Development (USAID) Not applicable https://govtribe.com/opportunity/federal-contract-opportunity/the-usaid-global-health-broad-agency-announcement-for-research-and-development-2018-globalhealthbaa2018
172 Call for proposals: 50×2030 data use grant competition – 2022 Researchers or groups of researchers living and working in one of the five countries where 50×2030 Data Use activities have begun: Cambodia, Ethiopia, Georgia, Senegal, and Uganda.  USD 8,000 Not Applicable 50×2030 Not Applicable https://www.50×2030.org/apply-data-use-research-grant-competition